Intranasal-CNS Delivery of ß-NAP Using Novel Simultaneous Spray Technology to Reverse Opiate & HIV-1 Induced Neurodegeneration Grant

Intranasal-CNS Delivery of ß-NAP Using Novel Simultaneous Spray Technology to Reverse Opiate & HIV-1 Induced Neurodegeneration .

date/time interval

  • March 1, 2017 - February 28, 2019

awarded by

administered by

sponsor award ID

  • #2400160